专利检索 ap:("CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.") AND inv:"Jie Li" 第 1 页

1.

发明授权
Isothiazolo[5,4-D]pyrimidine compound as IRAK4 inhibitor 有权

公开(公告)号：US11459337B2

公开(公告)日：2022-10-04

申请号：US17254778

申请日：2019-06-25

申请人： CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.

发明人： Yang Zhang , Jianfei Wang , Haizhong Tan , Jie Li , Jian Li , Shuhui Chen

IPC分类号： C07D513/04 , C07D519/00

摘要： Disclosed in the present invention are an IRAK4 inhibitor, and an application thereof in preparation of a drug for treating IRAK4-related diseases. Specifically disclosed are a compound represented by formula (III) and a pharmaceutically acceptable salt thereof.

2.

发明授权
Bicyclic compound as a caspase inhibitor 有权

公开(公告)号：US11434212B2

公开(公告)日：2022-09-06

申请号：US16479673

申请日：2018-01-23

申请人： CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.

发明人： Jianfeng Mou , Songliang Wu , Haiying He , Fengying Guo , Chuan Wang , Jie Li , Jian Li , Shuhui Chen

IPC分类号： C07D261/18 , C07D231/14 , C07D233/90 , C07D263/34 , C07D271/06 , C07D277/56

摘要： A compound represented by formula (I), a pharmaceutically acceptable salt or tautomer thereof, and an application of the compound as a caspase inhibitor.